StockData

Nexalin Technology vs QTREX Quantum

NXL and QTEX side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How NXL and QTEX compare

Nexalin Technology keeps more of each dollar of sales as profit, with a net margin of −4139% compared with −4574% at QTREX Quantum.

Nexalin Technology scores higher on the StockData Score (7 against 5 for QTREX Quantum), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricNXLQTEX
Size and price
Market cap$33.1M–
Share price$1.50$1.09
Change, 1 year−95.4%15.8%
Change, 5 years–−67.0%
Beta (5Y)2.79–
Employees830
StockData Score
Total score7 (better)5
Valuation score00
Growth score2 (better)0
Performance score00
Health score55
Dividend score00
Valuation
P/S152×–
P/B21.8×–
Growth
Revenue growth (TTM)24.2%–
Profitability
Gross margin86.2% (better)0.69%
Operating margin−4203% (better)−4714%
Net margin−4139% (better)−4574%
FCF margin–−3448%
Return on equity−240%−220% (better)
Return on invested capital−2105%–
Financial health
Debt / equity0.000.00
Current ratio1.252.00 (better)
Altman Z-score−41.74–
Piotroski F-score5 (better)3
Dividends and buybacks
Shareholder yield0.00%–
Ownership
Held by institutions0.13%7.5%
Held by insiders22.3%27.8%
Insider net buying, 12 months–−$218K
Short interest, % of float0.07%13.8%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.